Vaccination versus infection with SARS-CoV-2: Establishment of a high avidity IgG response versus incomplete avidity maturation.

Struck, Friedhelm; Schreiner, Patrick; Staschik, Eva; Wochinz-Richter, Karin; Schulz, Sarah; Soutschek, Erwin; Motz, Manfred; Bauer, Georg

Struck, Friedhelm; Schreiner, Patrick; Staschik, Eva; Wochinz-Richter, Karin; Schulz, Sarah; Soutschek, Erwin; Motz, Manfred; Bauer, Georg.

Affiliation

Struck F; Mikrogen GmbH, Neuried, Germany.
Schreiner P; Mikrogen GmbH, Neuried, Germany.
Staschik E; Mikrogen GmbH, Neuried, Germany.
Wochinz-Richter K; Mikrogen GmbH, Neuried, Germany.
Schulz S; Mikrogen GmbH, Neuried, Germany.
Soutschek E; Mikrogen GmbH, Neuried, Germany.
Motz M; Mikrogen GmbH, Neuried, Germany.
Bauer G; Institute of Virology, Medical Center-University of Freiburg, Freiburg, Germany.

J Med Virol ; 93(12): 6765-6777, 2021 Dec.

Article in En | MEDLINE | ID: mdl-34387884

Subject(s)

COVID-19/immunology; Immunoglobulin G/immunology; SARS-CoV-2/immunology; Antibodies, Viral/immunology; Antibody Formation/immunology; COVID-19/virology; COVID-19 Vaccines/immunology; Epitopes/immunology; Humans; Immunity, Herd/immunology; Immunologic Tests/methods; Spike Glycoprotein, Coronavirus/immunology; Vaccination/methods; Vaccines, Synthetic/immunology; mRNA Vaccines

Key words

SARS-CoV-2; avidity; protective immunity; receptor-binding domain; recomLine SARS-CoV-2 IgG; vaccination

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / SARS-CoV-2 / COVID-19 Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Med Virol Year: 2021 Document type: Article Affiliation country: Germany Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google